Actinomycetes biosynthetic potential: how to bridge in silico and in vivo?
about
Antibacterial Discovery and Development: From Gene to Product and BackMicrobial genome mining for accelerated natural products discovery: is a renaissance in the making?NextGen microbial natural products discoverySynthetic Biology of Natural Products.Exploiting a precise design of universal synthetic modular regulatory elements to unlock the microbial natural products in Streptomyces.Mycemycins A-E, New Dibenzoxazepinones Isolated from Two Different StreptomycetesSynthetic biology advances for pharmaceutical production.Genetic manipulation of secondary metabolite biosynthesis for improved production in Streptomyces and other actinomycetes.Natural products as a source of drug leads to overcome drug resistance.Insights into microbial cryptic gene activation and strain improvement: principle, application and technical aspects.Phylogeny-guided (meta)genome mining approach for the targeted discovery of new microbial natural products.Endophytic actinobacteria: Diversity, secondary metabolism and mechanisms to unsilence biosynthetic gene clusters.An efficient blue-white screening based gene inactivation system for Streptomyces.Identification of butenolide regulatory system controlling secondary metabolism in Streptomyces albus J1074.New natural products identified by combined genomics-metabolomics profiling of marine Streptomyces sp. MP131-18.Draft Genome Sequence of Kitasatospora griseola Strain MF730-N6, a Bafilomycin, Terpentecin, and Satosporin Producer.Actinomycetes: still a source of novel antibiotics.Genetic engineering combined with random mutagenesis to enhance G418 production in Micromonospora echinospora.Concepts and Methods to Access Novel Antibiotics from Actinomycetes.
P2860
Q26784492-18AC3743-8C22-409E-A1C7-5FABC9240E65Q33804081-EDB15614-A90B-45C0-9154-5F9658A9F4EFQ35062945-36BB1289-5A8A-4E35-B9DC-FCA4435E8419Q36098396-2D4048C2-ACEE-4AB3-A72E-1E8C928E2171Q36120216-E40C93B0-A78F-42B7-AEAC-A174A0654BD8Q36226749-C15683AA-55D3-444A-A245-B183C8B78FF6Q38368454-F00831E8-CBF8-4A88-9BBA-9C344CC167D3Q38585753-53DD2C8E-2083-4FDA-A94E-CE929D9131A0Q38620371-8AD12748-87C2-40DD-A805-3A0909A24B5CQ38887214-B2B053F0-1CAF-4E7C-838F-FBF057819D4DQ39019277-6074760C-2ACD-4856-9126-F3CD7C18A55FQ39208836-4AF79360-ECAD-4394-BF7A-2259E829F9F3Q41457244-198DA565-7E39-421B-B70A-98B6D2A4C6D2Q41550683-C378196C-32AD-44FE-A230-66A78ADE0000Q42110216-3FD98D53-B5AC-4C57-9CFA-1F20DB7E195CQ43215285-9BDB02F8-4237-4522-A70E-F43BB1CBF21FQ46319269-97FD6EC1-8D11-443C-90D8-B5EB984A1C3AQ53500312-72CC08EE-485D-4854-976C-25275ADC2951Q55404741-71B26EB4-64AE-4B18-AD23-EBFE7C28B3FC
P2860
Actinomycetes biosynthetic potential: how to bridge in silico and in vivo?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Actinomycetes biosynthetic potential: how to bridge in silico and in vivo?
@en
type
label
Actinomycetes biosynthetic potential: how to bridge in silico and in vivo?
@en
prefLabel
Actinomycetes biosynthetic potential: how to bridge in silico and in vivo?
@en
P2093
P2860
P1476
Actinomycetes biosynthetic potential: how to bridge in silico and in vivo?
@en
P2093
Andriy Luzhetskyy
Bogdan Tokovenko
Elke Brötz
Yuriy Rebets
P2860
P304
P356
10.1007/S10295-013-1352-9
P577
2013-10-15T00:00:00Z